Studie CC-5013-MDS-010 (PASS)

CC-5013-MDS-010 (PASS)

A prospective non-interventional post-authorization safety study (PASS), designed as a disease registry of patients with transfusion dependent IPSS low or intermediate-1-risk myelodysplastic syndrome (MDS) and isolated del(5q)

3. Med 3. Med Ismaninger Str. 22 81675 München Germany

Keine Phase

Rekrutierung beendet

Unbekannt / Unbekannt

Zielgerichtet